Description
GLP-1 + GIP Dual Receptor Agonist is a synthetic dual-acting incretin peptide engineered for stability and consistent activity in research environments. This peptide is widely studied in peptide research for its role in activating GLP-1 and GIP signaling pathways, regulating glucose metabolism, and supporting insulin secretion. This research peptide is commonly utilized in laboratory studies exploring pancreatic function, metabolic regulation, appetite control, and the molecular mechanisms underlying energy balance and endocrine signaling.
